Stoll Matthew L, Kumar Ranjit, Morrow Casey D, Lefkowitz Elliot J, Cui Xiangqin, Genin Anna, Cron Randy Q, Elson Charles O
Arthritis Res Ther. 2014 Nov 30;16(6):486. doi: 10.1186/s13075-014-0486-0.
Prior studies have established altered microbiota and immunologic reactivity to enteric commensal organisms in inflammatory bowel disease (IBD). Since intestinal inflammation is present in a subset of patients with both pediatric and adult spondyloarthritis (SpA), we hypothesized that SpA patients may also have altered microbiota and immune responsiveness to enteric organisms.
Stool and blood specimens were collected from children with enthesitis-related arthritis (ERA) and non-inflammatory controls. DNA purified from stool was subject to PCR amplification and sequencing of the variable IV region from the 16S rDNA gene. IgA and IgG Enzyme-linked Immunosorbent Assays (ELISAs) were performed on select species of bacteria in most subjects.
Twenty-five children with ERA and 13 controls were included. The ERA patients had less Faecalibacterium prausnitzii (3.8% versus 10%, P = 0.008) and lachnospiraceae family (12 versus 7.0%, P = 0.020), a statistically significant increase in bifidobacterium (1.8% versus 0%, P = 0.032) and a non-statistically significant increase in Bacteroides (21% versus 11%, P = 0.150). Akkermansia muciniphila was abundant (>2%) in 7/27 ERA patients but none of the controls (P = 0.072.) Cluster analysis revealed two clusters of ERA patients: Cluster one (n = 8) was characterized by high levels of Bacteroides genus, while a second (n = 15) cluster had similar levels as the controls. Seven of 17 (41%) of the ERA subjects in Cluster 2 compared to 0/8 of the subjects in Cluster 1 had abundant Akkermansia muciniphila (P = 0.057). Serum IgA and IgG antibody levels against F. prausnitzii and B. fragilis were similar between patients and controls, whereas the two groups showed divergent responses when the fecal relative abundances of F. prausnitzii and Bacteroides were compared individually against IgA antibody levels recognizing F. prausnitzii and B. fragilis, respectively.
The abundance of F. prausnitzii in the stool among patients with ERA is reduced compared to controls, and Bacteroides and A. muciniphila are identified as associative agents in subsets of ERA patients. Differences in the humoral responses to these bacteria may contribute to disease.
先前的研究已证实,炎症性肠病(IBD)患者的微生物群发生改变,且对肠道共生菌的免疫反应性也有所改变。由于小儿和成人脊柱关节炎(SpA)患者中有一部分存在肠道炎症,我们推测SpA患者的微生物群可能也发生了改变,并且对肠道细菌的免疫反应性也有所不同。
收集附着点炎相关关节炎(ERA)患儿和非炎症对照组儿童的粪便和血液样本。从粪便中提取的DNA进行PCR扩增,并对16S rDNA基因的可变IV区进行测序。对大多数受试者选择的细菌种类进行IgA和IgG酶联免疫吸附测定(ELISA)。
纳入25例ERA患儿和13例对照。ERA患者的普拉梭菌(3.8%对10%,P = 0.008)和毛螺菌科(12对7.0%,P = 0.020)较少,双歧杆菌有统计学意义的增加(1.8%对0%,P = 0.032),拟杆菌有非统计学意义的增加(21%对11%,P = 0.150)。7/27例ERA患者的嗜黏蛋白阿克曼菌丰富(>2%),而对照组均无(P = 0.072)。聚类分析显示ERA患者分为两组:第一组(n = 8)的特征是拟杆菌属水平较高,而第二组(n = 15)与对照组水平相似。第二组17例ERA受试者中有7例(41%)嗜黏蛋白阿克曼菌丰富,而第一组8例受试者中无一例(0/8)(P = 0.057)。患者和对照组之间针对普拉梭菌和脆弱拟杆菌的血清IgA和IgG抗体水平相似,而当分别将普拉梭菌和拟杆菌的粪便相对丰度与识别普拉梭菌和脆弱拟杆菌的IgA抗体水平进行比较时,两组显示出不同的反应。
与对照组相比,ERA患者粪便中普拉梭菌的丰度降低,拟杆菌和嗜黏蛋白阿克曼菌被确定为ERA患者亚组中的相关因素。对这些细菌的体液反应差异可能导致疾病。